Tag: Shockwave Medical
Shockwave Javelin peripheral IVL catheter meets prespecified efficacy and safety performance goals in feasibility and IDE studies
Shockwave Medical, part of Johnson & Johnson MedTech, has announced the first clinical outco...
EMPOWER CAD all-female IVL trial completes enrolment
Shockwave Medical has announced the completion of enrolment in EMPOWER CAD, the first prospective al...
Johnson & Johnson completes acquisition of Shockwave Medical
Johnson & Johnson today announced it has completed its acquisition of Shockwave Medical. Shockwa...
CMS creates new MS-DRG codes and payments for coronary IVL
Shockwave Medical has announced that as part of the Fiscal Year 2024 Medicare Hospital Inpatient Pro...
Shockwave Medical completes Neovasc acquisition
Shockwave Medical has announced the completion of its previously announced acquisition of Neovas...
Neovasc shareholders approve acquisition by Shockwave Medical
Neovasc has announced that its shareholders have approved the previously-announced acquisition o...
Shockwave Medical and Genesis MedTech obtain regulatory approval in China for intravascular lithotripsy
Shockwave Medical and Genesis MedTech Group announced today that they have successfully obtained app...
Shockwave completes enrolment in study of coronary intravascular lithotripsy
Shockwave Medical has completed enrolment in its US Food and Drug Administration (FDA) Investiga...
Shockwave commences IVL study to support regulatory approval in Japan
Shockwave Medical has initiated the DISRUPT CAD IV study of its intravascular lithotripsy (IVL) ...
Shockwave study demonstrates strong safety and procedural success of coronary IVL in Europe
Shockwave Medical, a company which provides intravascular lithotripsy (IVL) to treat complex cal...
Keith Dawkins appointed as chief medical officer at Shockwave Medical
Shockwave Medical has appointed Keith D Dawkins as its chief medical officer. In a press release...
A “crackdown” on alternative access for TAVI
The transfemoral approach is—by far—the most desirable access route for transcatheter ...
Shockwave initiates US pivotal study for coronary intravascular lithotripsy
Shockwave Medical has initiated its US Food and Drug Administration (FDA) Investigatio...
Abiomed invests $15 million in Shockwave Medical
A press release reports that Abiomed is to invest US$15 million in Shockwave Medical and the two...
Intravascular Lithotripsy for coronary artery disease launched in Europe
Intravascular Lithotripsy (Shockwave Medical) is now available, on the European market, for the mana...
Intravascular lithotripsy: A novel technology for treating calcified coronary stenoses
Intravascular lithotripsy, or IVL (Shockwave), is a novel procedure that is designed to deliver ...
